Authors: COLLINS JL SHEARER BG OPLINGER JA LEE SL GARVEY EP SALTER M DUFFY C BURNETTE TC FURFINE ES

Citation: Jl. Collins et al., N-PHENYLAMIDINES AS SELECTIVE INHIBITORS OF HUMAN NEURONAL NITRIC-OXIDE SYNTHASE - STRUCTURE-ACTIVITY STUDIES AND DEMONSTRATION OF IN-VIVO ACTIVITY, Journal of medicinal chemistry, 41(15), 1998, pp. 2858-2871

Authors: NG TI TALARICO C BURNETTE TC BIRON K ROIZMAN B

Citation: Ti. Ng et al., PARTIAL SUBSTITUTION OF THE FUNCTIONS OF THE HERPES-SIMPLEX VIRUS-1 U(L)13 GENE BY THE HUMAN CYTOMEGALOVIRUS U(L)97 GENE, Virology, 225(2), 1996, pp. 347-358

Authors: BURNETTE TC HARRINGTON JA REARDON JE MERRILL BM DEMIRANDA P

Citation: Tc. Burnette et al., PURIFICATION AND CHARACTERIZATION OF A RAT-LIVER ENZYME THAT HYDROLYZES VALACICLOVIR, THE L-VALYL ESTER PRODRUG OF ACYCLOVIR, The Journal of biological chemistry, 270(26), 1995, pp. 15827-15831

Authors: CHAMBERLAIN SD MOORMAN AR BURNETTE TC DEMIRANDA P KRENITSKY TA

Citation: Sd. Chamberlain et al., NOVEL CARBOHYDRATE CONJUGATES AS POTENTIAL PRODRUGS OF ACYCLOVIR, Antiviral chemistry & chemotherapy, 5(2), 1994, pp. 64-73

Authors: DEMIRANDA P BURNETTE TC

Citation: P. Demiranda et Tc. Burnette, METABOLIC-FATE AND PHARMACOKINETICS OF THE ACYCLOVIR PRODRUG VALACICLOVIR IN CYNOMOLGUS MONKEYS, Drug metabolism and disposition, 22(1), 1994, pp. 55-59

Authors: BURNETTE TC DEMIRANDA P

Citation: Tc. Burnette et P. Demiranda, METABOLIC DISPOSITION OF THE ACYCLOVIR PRODRUG VALACICLOVIR IN THE RAT, Drug metabolism and disposition, 22(1), 1994, pp. 60-64